News | November 03, 2021
Lancet endorses Sputnik Light for safety and immune response
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
Sputnik Light has been authorised in more than 15 countries with the registration process ongoing in a further 30 countries
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The agreement sharpens the company’s focus on priority medicines in respiratory & immunology portfolio
It is the first U.S. FDA approved novel topical mechanism for acne in nearly 40 years
The NFI is published to promote the rational use of medicines in the country.
Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
It launched the most advanced "DTAS" (Direct to Angio Suite) & State of the art ‘Neuro-Angio’ technology
The combined entity will have 12 hospitals with 3,666 beds
It plans to double its network to 50 centres across India in the next three years
Subscribe To Our Newsletter & Stay Updated
